JP2015533822A5 - - Google Patents

Download PDF

Info

Publication number
JP2015533822A5
JP2015533822A5 JP2015534689A JP2015534689A JP2015533822A5 JP 2015533822 A5 JP2015533822 A5 JP 2015533822A5 JP 2015534689 A JP2015534689 A JP 2015534689A JP 2015534689 A JP2015534689 A JP 2015534689A JP 2015533822 A5 JP2015533822 A5 JP 2015533822A5
Authority
JP
Japan
Prior art keywords
pyridin
pyrido
pyrimidin
cyclopropyl
piperazin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015534689A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015533822A (ja
JP6535430B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/062085 external-priority patent/WO2014052699A1/en
Publication of JP2015533822A publication Critical patent/JP2015533822A/ja
Publication of JP2015533822A5 publication Critical patent/JP2015533822A5/ja
Application granted granted Critical
Publication of JP6535430B2 publication Critical patent/JP6535430B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015534689A 2012-09-28 2013-09-27 非定型プロテインキナーゼcのアザキナゾリン阻害薬 Active JP6535430B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261707340P 2012-09-28 2012-09-28
US61/707,340 2012-09-28
US201361781364P 2013-03-14 2013-03-14
US61/781,364 2013-03-14
PCT/US2013/062085 WO2014052699A1 (en) 2012-09-28 2013-09-27 Azaquinazoline inhibitors of atypical protein kinase c

Publications (3)

Publication Number Publication Date
JP2015533822A JP2015533822A (ja) 2015-11-26
JP2015533822A5 true JP2015533822A5 (OSRAM) 2017-06-22
JP6535430B2 JP6535430B2 (ja) 2019-06-26

Family

ID=49326872

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015534689A Active JP6535430B2 (ja) 2012-09-28 2013-09-27 非定型プロテインキナーゼcのアザキナゾリン阻害薬

Country Status (18)

Country Link
US (2) US9914730B2 (OSRAM)
EP (1) EP2900666B1 (OSRAM)
JP (1) JP6535430B2 (OSRAM)
KR (1) KR102215272B1 (OSRAM)
CN (1) CN105102456B (OSRAM)
AU (1) AU2013323360B2 (OSRAM)
BR (1) BR112015007061B1 (OSRAM)
CA (1) CA2886495C (OSRAM)
CL (1) CL2015000781A1 (OSRAM)
EA (1) EA030253B1 (OSRAM)
IL (1) IL237918B (OSRAM)
MX (1) MX372736B (OSRAM)
NZ (1) NZ706857A (OSRAM)
PH (1) PH12015500689B1 (OSRAM)
SG (1) SG11201502301YA (OSRAM)
TW (1) TWI663165B (OSRAM)
WO (1) WO2014052699A1 (OSRAM)
ZA (1) ZA201502783B (OSRAM)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014052699A1 (en) * 2012-09-28 2014-04-03 Cephalon, Inc. Azaquinazoline inhibitors of atypical protein kinase c
US9868707B2 (en) 2012-12-20 2018-01-16 Sanford-Burnham Medical Research Institute Small molecule agonists of neurotensin receptor 1
DK2970283T3 (da) 2013-03-14 2021-01-25 Boehringer Ingelheim Int Substituerede 2-aza-bicyclo[2.2.1]heptan-3-carboxylsyre-(benzyl-cyano-methyl)-amider som inhibitorer af cathepsin-c
PH12019500143B1 (en) 2013-08-23 2023-03-24 Neupharma Inc Certain chemical entities, compositions, and methods
WO2015143376A1 (en) * 2014-03-21 2015-09-24 Nivalis Therapeutics, Inc. Novel compounds for the treatment of cystic fibrosis
TWI675836B (zh) 2014-03-25 2019-11-01 美商伊格尼塔公司 非典型蛋白質激酶c之氮雜喹唑啉抑制劑
JP6599908B2 (ja) * 2014-06-25 2019-10-30 サンフォード−バーンハム メディカル リサーチ インスティテュート ニューロテンシン受容体1の小分子アゴニスト
AR101106A1 (es) 2014-07-02 2016-11-23 Pharmacyclics Llc Inhibidores de tirosina quinasa de bruton
CN107074856A (zh) * 2014-09-05 2017-08-18 阿略斯泰罗斯医疗公司 CaMKII抑制剂及其用途
EP3191487B1 (en) 2014-09-12 2019-08-07 Boehringer Ingelheim International GmbH Spirocyclic inhibitors of cathepsin c
MX2017005346A (es) * 2014-10-29 2017-08-02 Dong A St Co Ltd Nuevos compuestos de piridopirimidinona para modular la actividad catalitica de histona lisina desmetilasas (kdm).
CN105288512A (zh) * 2015-12-08 2016-02-03 李野林 一种治疗肥胖症的中药组合物
PE20190971A1 (es) 2016-06-13 2019-07-09 Glaxosmithkline Ip Dev Ltd Compuestos quimicos
WO2018035061A1 (en) * 2016-08-15 2018-02-22 Neupharma, Inc. Certain chemical entities, compositions, and methods
EP3500569B1 (en) * 2016-08-16 2022-05-18 Merck Patent GmbH 2-oxo-imidazopyridines as reversible btk inhibitors and uses thereof
EP3515446B1 (en) 2016-09-19 2023-12-20 Novartis AG Therapeutic combinations comprising a raf inhibitor and a erk inhibitor
JOP20190257A1 (ar) * 2017-04-28 2019-10-28 Novartis Ag مركبات أريل غير متجانسة ثنائية الحلقة مندمجة 6-6 واستخدامها كمثبطات lats
CN110494166B (zh) 2017-05-02 2022-11-08 诺华股份有限公司 组合疗法
JP7039802B2 (ja) 2017-06-30 2022-03-23 ベイジン タイド ファーマシューティカル カンパニー リミテッド Rho-関連プロテインキナーゼ阻害剤、rho-関連プロテインキナーゼ阻害剤を含む医薬組成物、当該医薬組成物の調製方法及び使用
CN110573501B (zh) 2017-06-30 2023-09-29 北京泰德制药股份有限公司 Rho相关蛋白激酶抑制剂、包含其的药物组合物及其制备方法和用途
CA3063616A1 (en) 2017-06-30 2019-12-06 Beijing Tide Pharmaceutical Co., Ltd. Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and preparation method and use thereof
PE20211638A1 (es) * 2018-07-25 2021-08-24 Faes Farma Sa Piridopirimidinas como inhibidores del receptor de histamina h4
EP3831823A4 (en) * 2018-08-01 2022-04-27 Shanghai Ennovabio Pharmaceuticals Co., Ltd. PREPARATION AND USE OF AN AROMATIC COMPOUND WITH IMMUNEGULATORY FUNCTION
CN111100063B (zh) * 2018-10-25 2022-05-17 南京药石科技股份有限公司 一种合成2-氟甲基取代的吡咯烷、哌啶以及哌嗪衍生物的制备方法
CN114206865A (zh) * 2019-03-28 2022-03-18 癌症研究技术有限公司 非典型蛋白激酶C的抑制剂和其在治疗hedgehog途径依赖性癌症中的用途
KR102881316B1 (ko) 2019-05-13 2025-11-05 노파르티스 아게 암 치료를 위한 raf 억제제로서의 n-(3-(2-(2-하이드록시에톡시)-6-모르폴리노피리딘-4-일)-4-메틸페닐)-2 (트리플루오로메틸)이소니코틴아미드의 새로운 결정질 형태
CN116120243B (zh) * 2021-11-15 2025-07-29 都创(上海)医药科技股份有限公司 aPKC抑制剂化合物中间体片段及其制备方法和应用
CN114349711B (zh) * 2022-02-28 2023-08-15 四川依维欣医药科技有限公司 一种(R)-1-Boc-3-羟甲基哌嗪的合成方法
CN117088898A (zh) * 2022-05-13 2023-11-21 中国药科大学 稠环嘧啶类化合物及其制备方法、药物组合物和应用
CN120882714A (zh) * 2022-12-13 2025-10-31 风树疗法公司 {5-环丙基-2-[2-(3,6-二氟-吡啶-2-基氨基)-吡啶-4-基]-吡啶并[3,4-d]嘧啶-4-基}-((s)-3,3-二甲基-哌啶-4-基)-胺的固体形式

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4936700A (OSRAM) 1972-08-16 1974-04-05
US6184226B1 (en) * 1998-08-28 2001-02-06 Scios Inc. Quinazoline derivatives as inhibitors of P-38 α
JP2002080423A (ja) * 2000-09-06 2002-03-19 Daikin Ind Ltd トリフルオロ酢酸エチルの合成方法
ATE346064T1 (de) * 2000-09-15 2006-12-15 Vertex Pharma Pyrazolverbindungen als protein-kinasehemmer
FR2846657B1 (fr) 2002-11-05 2004-12-24 Servier Lab Nouveaux composes pyridopyrimidinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US7763627B2 (en) * 2003-04-09 2010-07-27 Exelixis, Inc. Tie-2 modulators and methods of use
US20050038047A1 (en) * 2003-08-14 2005-02-17 Edwards Paul John Azaquinazoline derivatives
US7582631B2 (en) * 2004-01-14 2009-09-01 Amgen Inc. Substituted heterocyclic compounds and methods of use
KR20070113252A (ko) * 2005-02-25 2007-11-28 쿠도스 파마슈티칼스 리미티드 2,4-디아미노-피리도피리미딘 유도체 및 이의 mTOR억제제로서의 용도
KR101438245B1 (ko) * 2006-08-23 2014-09-04 쿠도스 파마슈티칼스 리미티드 Mtor 억제제로서의 2-메틸모르폴린 피리도-, 피라조- 및 피리미도-피리미딘 유도체
EP2069344A2 (en) * 2006-09-08 2009-06-17 Pfizer Products Inc. Synthesis of 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
CA2773131C (en) * 2009-09-04 2015-07-14 The Regents Of The University Of Michigan Compositions and methods for treatment of leukemia
WO2014052699A1 (en) * 2012-09-28 2014-04-03 Cephalon, Inc. Azaquinazoline inhibitors of atypical protein kinase c
MX2015011576A (es) * 2013-03-13 2016-05-16 Univ Michigan Composiciones que comprenden compuestos de tienopirimidina y tienopiridina y metodos para usar los mismos.
WO2016040330A1 (en) * 2014-09-09 2016-03-17 The Regents Of The University Of Michigan Thienopyrimidine and thienopyridine compounds and methods of use thereof
EP3394064A1 (en) * 2015-12-22 2018-10-31 Vitae Pharmaceuticals, Inc. Inhibitors of the menin-mll interaction

Similar Documents

Publication Publication Date Title
JP2015533822A5 (OSRAM)
AU2013323360B2 (en) Azaquinazoline inhibitors of atypical protein kinase C
AU2019240299B2 (en) SHP2 phosphatase inhibitors and methods of use thereof
EP2558468B1 (en) 5, 7-substituted-imidazo [1,2-c] pyrimidines as inhibitors of jak kinases
JP2024532734A (ja) 複素環式化合物及び使用方法
KR101812357B1 (ko) Cdk4/6의 억제제로서의 피롤로피리미딘 화합물
CN117651700A (zh) 2-氨基苯并噻唑化合物及使用方法
WO2024107686A1 (en) Macrocyclic kras inhibitors and methods of use
JP2017518326A5 (OSRAM)
JP2018135377A (ja) Fgfr阻害剤としての置換三環式化合物
JP2015521600A5 (OSRAM)
HRP20160649T1 (hr) Novi derivati tienopirimidina, postupci za njihovo pripremanje i njihova terapeutska uporaba
HRP20151442T1 (hr) Spojevi heteroaril piridona i aza-piridona kao inhibitori btk-djelovanja
CA2687035A1 (en) Amino-heterocyclic compounds
JP2011511034A5 (OSRAM)
JP2015537010A5 (OSRAM)
JP2015504057A5 (OSRAM)
KR20120102724A (ko) 신규한 트리사이클릭 화합물
JP2017505327A5 (OSRAM)
MX2011001196A (es) Compuestos de pirimidina, composiciones y metodos de uso.
JP2021504380A5 (OSRAM)
JPWO2019156987A5 (OSRAM)
WO2025230862A1 (en) Macrocyclic amino compounds as modulators of kras and uses therof
WO2025230878A1 (en) Macrocyclic compounds as modulators of kras and uses thereof
WO2025194057A1 (en) Macrocyclic compounds as modulators of kras and uses thereof